Your browser doesn't support javascript.
loading
Atypical Mutation in Neisseria gonorrhoeae 23S rRNA Associated with High-Level Azithromycin Resistance.
Pham, Cau D; Nash, Evelyn; Liu, Hsi; Schmerer, Matthew W; Sharpe, Samera; Woods, Grace; Roland, Brad; Schlanger, Karen; St Cyr, Sancta B; Carlson, Jonathan; Sellers, Kevin; Olsen, Aaron; Sanon, Ruth; Hardin, Henrietta; Soge, Olusegun O; Raphael, Brian H; Kersh, Ellen N.
Afiliación
  • Pham CD; Centers for Disease Control and Prevention, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB, Atlanta, Georgia, USA whi4@cdc.gov.
  • Nash E; Centers for Disease Control and Prevention, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB, Atlanta, Georgia, USA.
  • Liu H; Centers for Disease Control and Prevention, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB, Atlanta, Georgia, USA.
  • Schmerer MW; Centers for Disease Control and Prevention, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB, Atlanta, Georgia, USA.
  • Sharpe S; Centers for Disease Control and Prevention, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB, Atlanta, Georgia, USA.
  • Woods G; Centers for Disease Control and Prevention, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB, Atlanta, Georgia, USA.
  • Roland B; Centers for Disease Control and Prevention, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB, Atlanta, Georgia, USA.
  • Schlanger K; Centers for Disease Control and Prevention, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB, Atlanta, Georgia, USA.
  • St Cyr SB; Centers for Disease Control and Prevention, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB, Atlanta, Georgia, USA.
  • Carlson J; San Francisco Department of Public Health, San Francisco, California, USA.
  • Sellers K; San Francisco Department of Public Health, San Francisco, California, USA.
  • Olsen A; New York City Department of Health and Mental Hygiene, New York, New York, USA.
  • Sanon R; Florida Department of Health, Tallahassee, Florida, USA.
  • Hardin H; Tennessee Department of Health, Knoxville, Tennessee, USA.
  • Soge OO; University of Washington, Seattle, Washington, USA.
  • Raphael BH; Centers for Disease Control and Prevention, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB, Atlanta, Georgia, USA.
  • Kersh EN; Centers for Disease Control and Prevention, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB, Atlanta, Georgia, USA.
Article en En | MEDLINE | ID: mdl-33139288

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Gonorrea / Azitromicina Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Gonorrea / Azitromicina Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos